Acceleron news from FierceBioResearcher
NewsThe race is on for muscle-enhancing therapies
The key to extraordinary muscle growth is inhibiting the gene that expresses myostatin, which blocks the growth of skeletal muscle. And now there's a race among a group of drug developers to bring a Read more...
| Press ReleasesPRESS RELEASE: Acceleron Pharma Completes $31M Series C Financing Acceleron Pharma Completes $31M Series C Financing Top venture syndicate invests to advance expanding pipeline of products that modulate tissue growth and repair Cambridge, Mass. – October 30, Read more... PRESS RELEASE: Acceleron Appoints John Knopf to CEO Spot Acceleron Appoints John Knopf to CEO Spot CAMBRIDGE, MA - September 18, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues Read more... |
Get more Acceleron coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight